DailyStocks Stock Article Search

https://seekingalpha.com/article/4796168-accenture-plc-acn-q3-2025-earnings-call-transcript?source=feed_sector_transcripts Jun 20, 2025 - 0

https://www.rttnews.com/story.aspx?Id=3524842 Mar 27, 2025 - Dermata Therapeutics, Inc. (DRMA) Thursday reported positive topline results from the pivotal Phase 3 STAR-1 study of the company's lead product candidate Xyngari for the treatment of acne. The study met its primary goals. The company's shares were more than 50 percent up in pre-market. 0

https://www.fool.com/investing/2024/11/27/this-magnificent-stock-has-made-many-millionaires/?source=iedfolrf0000001 Nov 27, 2024 - 0

https://www.fool.com/investing/2024/11/26/billionaire-ken-griffin-increased-citadels-positio/?source=iedfolrf0000001 Nov 26, 2024 - Billionaire hedge fund manager Ken Griffin just raised Citadel's position in global-consulting powerhouse Accenture. 0

https://seekingalpha.com/article/4723503-accenture-plc-acn-q4-2024-earnings-call-transcript?source=feed_sector_transcripts Sep 26, 2024 - Accenture plc (NYSE:ACN) Q4 2024 Earnings Conference Call September 26, 2024 8:00 AM ETCompany ParticipantsKatie O'Conor - Managing Director, Head of... 0

https://www.zacks.com/stock/news/2333686/accenture-acn-advances-but-underperforms-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2333686 Sep 09, 2024 - In the latest trading session, Accenture (ACN) closed at $341.81, marking a +0.58% move from the previous day. 0

https://www.zacks.com/stock/news/2323222/here-s-why-you-should-retain-accenture-acn-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2323222 Aug 16, 2024 - Accenture's (ACN) disciplined acquisition strategy focuses on channeling its business in high-growth areas, adding skills and capabilities, and deepening industry and functional expertise. 0

https://www.zacks.com/stock/news/2322528/accenture-acn-is-considered-a-good-investment-by-brokers-is-that-true?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2322528 Aug 15, 2024 - Based on the average brokerage recommendation (ABR), Accenture (ACN) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying? 0

https://www.zacks.com/stock/news/2322335/accenture-acn-advances-but-underperforms-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2322335 Aug 14, 2024 - Accenture (ACN) closed at $319.83 in the latest trading session, marking a +0.16% move from the prior day. 0

https://www.zacks.com/stock/news/2319573/accenture-acn-stock-falls-amid-market-uptick-what-investors-need-to-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2319573 Aug 08, 2024 - In the most recent trading session, Accenture (ACN) closed at $315.88, indicating a -0.67% shift from the previous trading day. 0